Revenio Group Oyj
REG1V.HE
Get informed when a big investor buys or sells
+ FollowMarket Cap$322.91M
Close$
$16.79
49.9% upside
Current Fair Value
49.9% upsideUndervalued by 49.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $322.91 Million |
|---|---|
| Enterprise Value | $563.91 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.65 |
| Beta | 0.88 |
| Outstanding Shares | 30,000,000 |
Return
| Return on Equity | 8.83% |
|---|---|
| Return on Assets | 2.75% |
| Return on Invested Capital | 5.86% |
Valuation & Multiples
| P/E Ratio | 22.56 |
|---|---|
| PEG | -27.98 |
| Price to Sales | 2.8 |
| Price to Book Ratio | 2.8 |
| Enterprise Value to Revenue | 4.56 |
| Enterprise Value to EBIT | 32.22 |
| Enterprise Value to Net Income | 42 |
| Total Debt to Enterprise | 0.46 |
| Debt to Equity | 1.73 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 8, 2026
EPS Estimate
$0.10
Average shareholder expectationRevenue Estimate
$40.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 12, 2026
EPS Estimate
$0.09
Average shareholder expectationRevenue Estimate
$59.82 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Revenio Group Oyj
247 employees
CEO: Jouni Erik Toijala Revenio Group Oyj operates as a healthcare technology company, specializing in the development, production, and global distribution of advanced ophthalmic diagnostic instruments and medical devices. These innovations are engineered to ai...